
他莫昔芬与年轻乳腺癌幸存者子宫疾病风险:靶向试验模拟研究的证据
一项大规模队列研究表明,辅助他莫昔芬显著增加绝经前女性子宫内膜癌、增生和息肉的风险,且风险与治疗时间相关。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.